AMGEN Inc.

NASDAQ:AMGN 4:00:00 PM EDT

241.50

+0.47 (+0.20%)

4:39:19 PM EDT: $241.50 0.00 (0.00%)

Products

Amgen's Tezspire gets FDA Approval For Self-Administration For Patients With Severe Asthma

Published: 02/02/2023 14:37 GMT

AMGEN Inc. (AMGN) - Amgen - Announced FDA Approved Tezspire for Self-administration in Pre-filled, Single-use Pen for Patients Aged 12 Years & Older With Severe Asthma.
Amgen Inc - FDA Has Approved Tezspire for Self-administration in U.S. With a New Pre-filled Pen.